Recombinant herpes zoster vaccine in patients with autoimmune rheumatic diseases in Brazil: a double-blind, randomised, placebo-controlled, phase 4, non-inferiority study
{{output}}
Background: Patients with autoimmune rheumatic diseases are at high risk of developing herpes zoster due to immunosuppressive treatment. We evaluated the effect of a recombinant zoster vaccine in patients with autoimmune rheumati... ...
